LB Pharmaceuticals Publishes Phase 2 Schizophrenia Trial in JAMA
22 Apr 2026 //
GLOBENEWSWIRE
LB Pharma Presents NOVA-1 LB-102 Cognition Data at SIRS Society
27 Mar 2026 //
GLOBENEWSWIRE
LB Pharma Starts Pivotal Ph 3 Trial of LB-102 in Schizophrenia
25 Mar 2026 //
GLOBENEWSWIRE

Market Place
Sourcing Support